Early administration of the GIP receptor antagonist (Pro(3))GIP counters development of hyperglycaemia, glucose intolerance and insulin resistance in genetic obesity

Autoria(s): Flatt, P.R.; Irwin, N.; McClean, P.L.; Green, Brian; Gault, V.A.; Bailey, C.J.; O'Harte, F.P.M.
Data(s)

2006
Identificador

http://pure.qub.ac.uk/portal/en/publications/early-administration-of-the-gip-receptor-antagonist-pro3gip-counters-development-of-hyperglycaemia-glucose-intolerance-and-insulin-resistance-in-genetic-obesity(c0a2e54d-a6cb-4e66-b90a-dd3e37019291).html
Idioma(s)

eng
Direitos

info:eu-repo/semantics/restrictedAccess
Fonte

Flatt , P R , Irwin , N , McClean , P L , Green , B , Gault , V A , Bailey , C J & O'Harte , F P M 2006 , ' Early administration of the GIP receptor antagonist (Pro(3))GIP counters development of hyperglycaemia, glucose intolerance and insulin resistance in genetic obesity ' Diabetologia , vol 49 , pp. 108-109 .
Tipo

article
Acesso ao item digital